Rights and permissions
About this article
Cite this article
Cost-effectiveness thresholds too low, refinement needed. Pharmacoecon. Outcomes News 425, 2 (2003). https://doi.org/10.1007/BF03276628
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03276628